Table 1 Clinical characteristics of patients infected with SARS-CoV-2
Variables | Total (n = 164) |
|---|---|
Gender. no (%) | |
Male | 92 (56.1) |
Female | 72 (43.9) |
Age | 54.0 (15.1) |
Initial vital sign mean (SD) | |
RR breaths/min | 19.2 (2.8) |
Temp | 37.0 (0.9) |
PR | 99.1 (19.2) |
SBP | 130.2 (20.1) |
DBP | 79.3 (12.7) |
O2 SAT | 91.0 (6.5) |
Symptoms. no (%) | |
Cough | 118 (71.8) |
Fever | 83 (50.9) |
Chill | 60 (36.8) |
Dyspnea | 93 (57.1) |
Sore throat | 30 (18.4) |
Headache | 51 (31.3) |
Dizziness | 37 (22.7) |
Weakness | 80 (49.1) |
Muscular pain | 75 (46.0) |
Diarrhea | 27 (16.6) |
Abdominal pain | 14 (8.6) |
Anorexia | 73 (44.8) |
Nausea | 52 (31.9) |
Vomiting | 30 (18.4) |
Comorbidity no (%) | |
Diabetes | 38 (23.3) |
Hyperlipidemia | 10 (6.1) |
Hypertension | 38 (23.3) |
Chronic heart disease | 24 (14.7) |
Chronic kidney disease | 1 (0.6) |
Asthma | 11 (6.7) |
COPD | 0 (0.0) |
Cirrhosis | 0 (0.0) |
Autoimmune disease | 1 (0.6) |
History of malignancy | 1 (0.6) |
Recent chemoradiotherapy | 1 (0.6) |
Current steroid use | 1 (0.6) |
Immunosuppressant drug use | 1 (0.6) |